Powered by
ANN ARBOR—Celsee Inc., the single-cell isolation and analysis developer, announced an agreement to provide scientists at China’s Kindstar Global, a medical testing service,with Celsee’s Genesis System for monitoring circulating tumor …
ANN ARBOR—Millendo Therapeutics Inc. (Nasdaq: MLND), the developer of new endocrine drugs, announced the promotion of Thomas Hoover to the newly created position of chief commercial officer. Hoover joined Millendo …
ANN ARBOR—Millendo Therapeutics Inc. (Nasdaq: MLND), a biopharmaceutical company primarily focused on developing novel treatments for orphan endocrine diseases with significant unmet needs, announced that Geoff Nichol has been appointed …
ANN ARBOR—Domino’s Pizza Inc. (NYSE: DPZ) announced that after successful testing in 2019, its GPS delivery tracking technology has now been expanded to about a quarter of its stores across …
ANN ARBOR–Kraig Biocraft Laboratories Inc. (OTC: KBLB) announced that it has completed the hatching of the second generation of its genetically engineered silkworms as it expands production at its breeding …
ANN ARBOR—Phenomics Health Inc., a University of Michigan research spinout that aims to increase the precision of pharmaceuticals by using individual people’s genetic information, announced it acquired patented pharmacometabolomic technology …
ANN ARBOR–The latest Finance, Insurance, and Health Care Report from the Ann Arbor-based American Customer Satisfaction Index showed that banks have surpassed credit unions in customer satisfaction, an ACSI first. …
ANN ARBOR — Kraig Biocraft Laboratories Inc. (OTCQB: KBLB), the Ann Arbor-based developer of genetically engineered silk fibers, announced that its Vietnamese subsidiary Prodigy Textiles completed the first cycle of …
ANN ARBOR—Millendo Therapeutics Inc., (Nasdaq: MLND), a clinical-stage pharmaceutical company primarily focused on developing novel treatments for orphan endocrine diseases with significant unmet needs, provided a corporate update and reported …
FARMINGTON HILLS—Ocuphire Pharma Inc., a startup pharmaceutical company focused on the development and commercialization of therapies to treat patients with a variety of ophthalmic disorders, announced statistically significant and clinically …